David Ruano-Gallego

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Analytical chemistry

Nature communications

PLoS pathogens

Science (New York, N.Y.)

Centro de Astrobiología

Universidad Autónoma de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro de Astrobiología May 04 2020

Spain

Research associate :: Molecular Evolution

Universidad Francisco de Vitoria Nov 01 2019

Spain

Assistant Lecturer :: Ciencias Experimentales

Imperial College London Nov 01 2015 - Sep 29 2019

United Kingdom

Research asociate :: MRC Centre for Molecular Microbiology and Infection (CMBI)

Centro Nacional de Biotecnología Apr 01 2015 - Sep 01 2015

Spain

Postdoctoral Fellow :: Microbial Biotechnology

Education History

Universidad Autónoma de Madrid Sep 01 2009 - Dec 12 2014

Spain

PHD :: Molecular Biology

Universidad Autónoma de Madrid Oct 01 2008 - Jul 01 2009

Spain

MSC :: Molecular Biology

Publications

Pedro Mustieles-Del-Ser, David Ruano-Gallego, Víctor Parro
Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration. Analytical chemistry (2024)
Pedro Mustieles-Del-Ser, David Ruano-Gallego, Víctor Parro
Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration. Analytical chemistry 96 (12) (2024)
Pedro Mustieles-Del-Ser, David Ruano-Gallego, Víctor Parro
Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration. Analytical chemistry 96 (12) (2024)
Pedro Mustieles-Del-Ser, David Ruano-Gallego, Víctor Parro
Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration. Analytical chemistry 96 (12) (2024)
Pedro Mustieles-Del-Ser, David Ruano-Gallego, Víctor Parro
Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration. Analytical chemistry 96 (12) (2024)
Pedro Mustieles-Del-Ser, David Ruano-Gallego, Víctor Parro
Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration. Analytical chemistry 96 (12) (2024)
David Ruano-Gallego, Julia Sanchez-Garrido, Zuzanna Kozik, Elena Núñez-Berrueco, Massiel Cepeda-Molero, Caroline Mullineaux-Sanders, Jasmine Naemi-Baghshomali Clark, Sabrina L Slater, Naama Wagner, Izabela Glegola-Madejska, Theodoros I Roumeliotis, Tal Pupko, Luis Ángel Fernández, Alfonso Rodríguez-Patón, Jyoti S Choudhary, Gad Frankel
Type III secretion system effectors form robust and flexible intracellular virulence networks. Science (New York, N.Y.) 371 (6534) (2021)
David Ruano-Gallego, Miriam García Villadangos, Mercedes Moreno-Paz, Javier Gómez-Elvira, Marina Postigo, María Simón-Sacristán, Hugh T Reyburn, Carlo Carolis, Natalia Rodrigo, Yaiza B Codeseira, Paloma Rueda, Sonia Zuñiga, Luis Enjuanes, Victor Parro
A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS-CoV-2 reveals higher seroprevalence than reported. Microbial biotechnology 14 (3) (2021)
David Ruano-Gallego, Daniel A Yara, Lorenza Di Ianni, Gad Frankel, Stephanie Schüller, Luis Ángel Fernández
A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa. PLoS pathogens 15 (8) (2019)
James P R Connolly, Sabrina L Slater, Nicky O'Boyle, Robert J Goldstone, Valerie F Crepin, David Ruano-Gallego, Pawel Herzyk, David G E Smith, Gillian R Douce, Gad Frankel, Andrew J Roe
Author Correction: Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion. Nature communications 9 (1) (2018)
James P R Connolly, Sabrina L Slater, Nicky O'Boyle, Robert J Goldstone, Valerie F Crepin, David Ruano-Gallego, Pawel Herzyk, David G E Smith, Gillian R Douce, Gad Frankel, Andrew J Roe
Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion. Nature communications 9 (1) (2018)

David Ruano-Gallego.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Ruano-Gallego